Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: Acta Histochem. 2007 Dec 18;110(3):182–195. doi: 10.1016/j.acthis.2007.10.003

Figure 3.

Figure 3

A summary of the best-known markers for the different stages of development of the oligodendrocyte. Not all researchers agree on the arbitrary stages of development shown here, but this combined figure highlights most of the current research on their development. OPC (oligodendrocyte precursor cell); O-2A (oligodendrocyte-astrocyte type 2A precursor); Olig (oligodendrocyte marker-1 and 2); PDGF (platelet derived growth factor); αvβ1 (integrin alpha v and beta-1 subunits); GD3 (ganglioside 3); A2B5; αvβ3; O4 (oligodendrocyte marker-4); NG2 (chondroitin sulfate proteoglycan); 14F7 (for an antibody with that nomenclature); αvβ5; MAG (myelin-associated glycoprotein); PLP/DM20 (proteolipid protein); O1 (oligodendrocyte marker-1); MBP (myelin basic protein).

HHS Vulnerability Disclosure